• A Patient Survey Regarding Risk of Opioid Abuse- Results of A Pilot Study

    Nov 1, 2016, 00:00

  • Life Expectancy, Quality-Adjusted Life Years, and Total Lifetime Costs for Australian People with Multiple Sclerosis

    Nov 1, 2016, 00:00

  • Cost of Ebola Virus Disease Diagnosis Using Rapid Point-Of-Care Diagnostics in Sierra Leone

    Nov 1, 2016, 00:00

  • Treatment Gap of Post Osteoporotic Fractures in Taiwan- A Nationwide Cohort Study, 2008-2013

    Nov 1, 2016, 00:00

  • Cost Effectiveness Analysis of A Flash Glucose Monitoring System for Type 2 Diabetes (T2DM) Patients Receiving Intensive Insulin Treatment in Europe

    Nov 1, 2016, 00:00

  • Can Pharmaceutical Care Intervention Improve Lipid Profile in Type 2 Diabetes Patients; A Prospective Intervention Study in a Tertiary Hospital in Nigeria

    Nov 1, 2016, 00:00

  • Medication Cost Of Acute Myeloid Leukemia- A Descriptive Study

    Nov 1, 2016, 00:00

  • Longitudinal Trajectories of Depressive and Anxious Symptoms Following a Self-Management Intervention for Haemodialysis Patients

    Nov 1, 2016, 00:00

  • EFFECTIVENESS OF THE TRX SUSPENSION TRAINER IN PEOPLE WITH OSTEOARTHRITIS

    Nov 1, 2016, 00:00

  • Assessing Statin-Associated Myopathy using Administrative Data from a German Health Insurance Fund- Results of a Pilot Study

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Tiotropium Versus Glycopyrronium In Moderate To Very Severe COPD In France

    Nov 1, 2016, 00:00

  • Antimicrobial Agents Dispensing In Upper Respiratory Tract, Gastrointestinal Tract Infections And Infected Wound In Thai Drug Stores In 2015

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Lipegfilgrastim in Prophylaxis of Febrile Neutropenia in Cancer Patients

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of H. Pylori Eradication Treatment Regimens in Peptic Ulcer Disease in Ukraine

    Nov 1, 2016, 00:00

  • The Health Economics Analysis of Unqualified Venous Blood Samples In The Chinese Tertiary Referral Hospital

    Nov 1, 2016, 00:00

  • Healthcare Costs of Inflammatory Bowel Disease in The Biologic Era- A Study Of 2,451 Patients with Twelve years Follow-Up Evaluation

    Nov 1, 2016, 00:00

  • Comorbidities in HIV-1- A Literature Review of the Associations Between Patient- and Disease-Related Factors and Non-Aids Related Comorbidities (NARCS)

    Nov 1, 2016, 00:00

  • Castration-Resistant Prostate Cancer (CRPC)- Evaluation of The Quality of Care and Disease Management in Real-Life Setting

    Nov 1, 2016, 00:00

  • Willingness To Pay For Primary Dysmenorrhea Health States

    Nov 1, 2016, 00:00

  • Estimating The Economic and Clinical Benefits of Mirabegron Versus Antimuscarinics for The Treatment of Overactive Bladder (OAB) in The United Kingdom (UK)

    Nov 1, 2016, 00:00

  • Comparison of Informal Caregiving Time Required by Alzheimer's Disease Patients and Mild Cognitive Impairment Patients

    Nov 1, 2016, 00:00

  • Treatment Patterns of Rheumatoid Arthritis in Japanese Hospitals and Predictors of Initiation Biologic Agents

    Nov 1, 2016, 00:00

  • Predictors of First Line Treatment Persistence Among Patients with Metastatic Renal Cell Carcinoma in The United States, Western Europe, and Japan

    Nov 1, 2016, 00:00

  • Cost Minimisation Analysis Of Follitropin Delta Versus Follitropin Alfa In Assisted Reproductive Technologies (Ivf/Icsi) In The United Kingdom

    Nov 1, 2016, 00:00

  • Using Orthogonal Design in Selecting Health States for the Construction of EQ-5D-3L Value Set

    Nov 1, 2016, 00:00

  • A Study on Identification, Monitoring and Management of Adverse Drug Reactions in a Tertiary Care Hospital

    Nov 1, 2016, 00:00

  • Perliminary Study of Medication Regimen Complexity Among Taiwanese Elderly who Have Used Anxiety or Hypnotics Prescriptions

    Nov 1, 2016, 00:00

  • Costs And Quality of Life of Low Back Pain- A Multi-Register Based National Treatment Pathway Model In Sweden

    Nov 1, 2016, 00:00

  • Investigating Performance Indicators and Service Quality Improvement in an Outpatient Cardiology Department

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Caspofungin Versus Voriconazole in the Empirical Antifungal Therapy of Febrile Neutropenia in China

    Nov 1, 2016, 00:00

  • Rheumatoid Arthritis- Treatment Sequencing in Guidelines Compared to Real-World Evidence. A German Claims Data Analysis

    Nov 1, 2016, 00:00

  • Societal Implications of Medical Insurance Coverage for Imatinib as First-Line Treatment of Chronic Myeloid Leukaemia in China- A Cost Effectiveness Analysis

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Continuous Intraduodenal Levodopa Intestinal Gel Infusion in the Treatment of Advanced and Severe Forms of Parkinson's Disease

    Nov 1, 2016, 00:00

  • Survival And Death Risk of Patients With Prostate Cancer Treated In The Brazilian Public Health System

    Nov 1, 2016, 00:00

  • Two-Year Antecedent Versus Subsequent Diagnoses of Patients Newly Diagnosed with Primary Restless Legs Syndrome- A Large-Scale Retrospective Claims Analysis

    Nov 1, 2016, 00:00

  • Detection and Analysis of Therapy Lines and Other Event Sequences in Claims Data

    Nov 1, 2016, 00:00

  • Comparative Analysis Of Medication Possession Ratio Measures For Adherence To Single-Medication

    Nov 1, 2016, 00:00

  • Economic Impact of Macular Edema Diseases in Italy

    Nov 1, 2016, 00:00

  • A Retrospective Analysis of Heart Failure Prescription Adherence and the Hospitalization Outcome- A Tertiary Medical Center Experience in Taiwan

    Nov 1, 2016, 00:00

  • Adherence to Osteoporosis Drugs and Clinical Outcomes Among Osteoporosis Patients with Different Risk Profiles

    Nov 1, 2016, 00:00

  • Developing HTA Guidelines for Rare Disease Therapies - an Industry Perspective

    Nov 1, 2016, 00:00

  • The Economic Burden of Multiple Sclerosis in Spain- A Population Based Study

    Nov 1, 2016, 00:00

  • Ethical Standards In Reporting Research From Retrospective Observational Studies Based On Databases Using Anonymous And Personally Unidentifiable

    Nov 1, 2016, 00:00

  • Health Technology Assessment in Argentina- At what Point in the Life-Cycle of Technologies are they Requested

    Nov 1, 2016, 00:00

  • Predicting Orphan Designation And Marketing Authorisation Based On A Review Of The European Medicines Agency Orphan Disease Register

    Nov 1, 2016, 00:00

  • Patient Characteristics and Clinical Outcomes of Patients with Liver Cancer in a Tertiary-Care Hospital in Malaysia

    Nov 1, 2016, 00:00

  • Need of Cosmetovigilance in India

    Nov 1, 2016, 00:00

  • Willingness to Pay For A Quality-Adjusted Life Year of Outpatients with Cardiovascular Diseases

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Rotavirus Vaccination in Hangzhou, China- A Comparison Between two Vaccines

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Cancer Risk Reduction Strategies for BRCA Mutation Carriers

    Nov 1, 2016, 00:00

  • Effectiveness And Cost-Effectiveness of The Salut Programme – A Universal Health Promotion Intervention For Parents And Children

    Nov 1, 2016, 00:00

  • Getting Medical Innovation to Patients in Developing Countries - A Systemic Approach to Setting Price and Access

    Nov 1, 2016, 00:00

  • Evaluation Of The Value Of Pharmaceutical Products In Taiwan

    Nov 1, 2016, 00:00

  • A New Organizational Integrated Home-Care Model- An Italian Pilot Study

    Nov 1, 2016, 00:00

  • Subject Recommendations for Improving Their Compliance in Completing Electronic Diaries in Depression Clinical Trials

    Nov 1, 2016, 00:00

  • Well-Being- What Is It, How Does it Compare to Health and What are the Implications of Using it to Inform Health Policy?

    Nov 1, 2016, 00:00

  • Economic Burden of Maintaining Vascular Access Patency in Patients with Hemodialysis Fistulas - A National Population-Based Study

    Nov 1, 2016, 00:00

  • Correlation Between Structural Damage and Work/Activity Impairment Among Rheumatoid Arthritis Patients

    Nov 1, 2016, 00:00

  • Budget-Impact Analysis (Bia) Of The Introduction Of 52mg Levonorgestrel-Releasing Intrauterine System (Lng-Ius) As A Contraceptive Method Option In The Brazilian Public Healthcare System (Sus) To Avoid Unintended Pregnancy (Up) In 15 To 19 ...

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Of Acupuncture Treatment In Mental Disorder- A Systematic Review

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Nivolumab for the Treatment Of Advanced Non-Squamous Non-Small Cell Lung Cancer (Nsclc) In Saudi Arabia

    Nov 1, 2016, 00:00

  • Improvement of Long Term Risks of Cardiovascular Events Associated with Community Based Disease Management in Chinese Patients of the Xin Jiang Autonomous Region of China

    Nov 1, 2016, 00:00

  • Surgical Site Complications- to Prevent or Not to Prevent? A Budget Impact Analysis in the Hospital Setting

    Nov 1, 2016, 00:00

  • The Impact of Dementia on the Outcomes of Treatments For Acute Coronary Syndrome

    Nov 1, 2016, 00:00

  • Autoinjector Preference Among Patients with Multiple Sclerosis- Results From A National Survey

    Nov 1, 2016, 00:00

  • Knowledge, Attitude and Practice (KAP) Regarding Blood Donation Among Health Care Workers in Malaysia

    Nov 1, 2016, 00:00

  • Prioritizing Medication Problems in Care of People with Cancer and Solutions For These- A Prioritize Study

    Nov 1, 2016, 00:00

  • Budget Impact Analysis of Sunitinib Versus Best Supportive Care for The Treatment of Metastatic Renal Cell Carcinoma in Chile

    Nov 1, 2016, 00:00

  • Informal Care and Productivity Losses are Important in Advanced Cutaneous Melanoma- Results of the Dutch Melanoma Treatment Registry

    Nov 1, 2016, 00:00

  • An Assessment Of Biosimilars’ Behaviour In The Eu-5 Countries

    Nov 1, 2016, 00:00

  • What EU Mean to the MHRA! Potential Impact of ‘Brexit’ on Pharmaceutical Regulation in the UK

    Nov 1, 2016, 00:00

  • Rate and Healthcare Utilization (Los and Costs) of Adhesion Related Complications after Colon Resection Procedures

    Nov 1, 2016, 00:00

  • Global Prevalence Estimates of Transthyretin Familial Amyloid Polyneuropathy (ATTR-FAP)- A Systematic Review and Projections

    Nov 1, 2016, 00:00

  • Possible Explanations as to Why Effective Products Still Don't Have a Price in France

    Nov 1, 2016, 00:00

  • Estimating the Economic Burden of Treatment Resistant Depression in Taiwan using the NHIRD

    Nov 1, 2016, 00:00

  • Certolizumab Pegol is Associated with Long-Term Improvements in Patient-Reported Outcomes in Psoriatic Arthritis- 4-Year Outcomes from the Rapid-Psa Study

    Nov 1, 2016, 00:00

  • Supply-Side and Demand-Side Policies for Biosimilars- An Overview in 10 European Member States

    Nov 1, 2016, 00:00

  • Landscape of Advanced NSCLC- The Impact of Upcoming Therapies

    Nov 1, 2016, 00:00

  • Health Insurance Cost Of Multiple Sclerosis In Hungary- A Cost Of Illness Study

    Nov 1, 2016, 00:00

  • When Should Translations of Clinical Outcome Assessments (COAS) be Considered Obsolete? Recommendations from MAPI’S Translations Life Expectancy Working Group

    Nov 1, 2016, 00:00

  • Factors Associated with 90-Day or 180-Day Long-Term Use of Anxiety-Hypnotic Prescriptions and Economic and Safety Outcomes- A Retrospective Cohort Study

    Nov 1, 2016, 00:00

  • Empirical Calibration of Hepatitis C Virus (HCV) Natural History Model to the Chinese HCV-Infected Population

    Nov 1, 2016, 00:00

  • Current Status of Endoscopic Submucosal Dissection for Gastric Cancer Within Absolute Indication in Korea- Based on National Claims Database

    Nov 1, 2016, 00:00

  • How are Budget Impact Considerations Captured within Economic Evaluations? A Systematic Review of the Literature Focused on Rotavirus Vaccine

    Nov 1, 2016, 00:00

  • The Multidisciplinary Risk Assessment and Management Program – Diabetes Mellitus (Ramp-Dm) was Cost-Effective for Managing Patients with Diabetes Mellitus

    Nov 1, 2016, 00:00

  • Economic Burden of Community-Acquired Pneumonia Among Elderly

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Xpert MTB/RIF Assay for Diagnosing Tuberculosis in Malaysia Using Dynamic Transmission Model

    Nov 1, 2016, 00:00

  • Retrospective Database Analysis of Hospital Length of Stay, Discharge Location, And Readmissions Among Patients Undergoing Total Knee Arthroplasty (TKA) In The United States

    Nov 1, 2016, 00:00

  • • Analysis of The Factors Affecting Parents’ Medication Adherence In Asthmatic Children Using Expectation Confirmation Theory

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Combination Therapy with Dutasteride/Tamsulosin- An Analysis Based on Conduct Trial

    Nov 1, 2016, 00:00

  • Real-World Treatment Pattern in Community Patients with Type-2 Diabetes- Evidence from Shanghai, China

    Nov 1, 2016, 00:00

  • Pain Management of Lung Cancer Patient in Hungary

    Nov 1, 2016, 00:00

  • The Importance of Conitec Recommendation about Analogues Insulins of The Treatment of Diabetes Type 1

    Nov 1, 2016, 00:00

  • Are Component Endpoints Equal? A Study into the Practice of Composite End Points in Clinical Trials

    Nov 1, 2016, 00:00

  • Medical Care Costs of Diabetes Using an Instrumental Variable Approach

    Nov 1, 2016, 00:00

  • Cost Utility of Transfer Factor In The Treatment of Recurrent Infection`S Episodes In Adult And Pediatric Subjects From A Final Results From Multicentre Observational Study

    Nov 1, 2016, 00:00

  • Diabetic Macular Edema, Budget Impact Analysis from the Perspective of the Algerian Public Health System

    Nov 1, 2016, 00:00

  • Man Versus Machine - Is Accurate Automation of Data Abstraction Achievable?

    Nov 1, 2016, 00:00

  • Current and Preferred Status on HTA Implementation- A Ukrainian Perspective

    Nov 1, 2016, 00:00

  • Use of Novel Health-Related Quality of Life Measures to Assess The Effect of Metamorphopsia Symptoms In Patients with Vitreomacular Traction, With or Without Macular Hole- The Memo Study

    Nov 1, 2016, 00:00

  • A Health Technology Assessment of Home-Based Haemodialysis in Esrd Patients

    Nov 1, 2016, 00:00

  • Adaptive Reimbursement Model- How to Correlate The Price to The Level of Evidences During The Entire Drug Life Cycle

    Nov 1, 2016, 00:00

  • Comparative Efficacy of Daratumumab Monotherapy and Pomalidomide Plus Low Dose Dexamethasone (POMA+LODEX) in The Treatment of Multiple Myeloma - A Matching Adjusted Indirect Comparison (MAIC)

    Nov 1, 2016, 00:00

  • Psychometric Validation Of Four Patient-Reported Outcome Instruments In A Diverse Sample Of Adults With Chronic Hepatitis C Virus Infection Treated With Simeprevir And Sofosbuvir

    Nov 1, 2016, 00:00

  • Cone Beam Computed Tomography use in Overdenture Abutments Examination- Risk Benefit Analysis

    Nov 1, 2016, 00:00

  • Recent Trends in Percutaneous Coronary Intervention Volume in the United States

    Nov 1, 2016, 00:00

  • Issues Related to the Frequency of Exploratory Analyses by Evidence Review Groups in the Nice Single Technology Appraisal Process

    Nov 1, 2016, 00:00

  • Dimensionality Of Value- Are The Us And Europe Moving Towards Similar Or Different Definitions Of Pharmaceutical Value?

    Nov 1, 2016, 00:00

  • Ofatumumab As A Combination Therapy Versus Other Treatment Regimens in Patients with Untreated, Relapsed or Refractory Chronic Lymphocytic Leukaemia- A Systematic Review of Randomised Controlled Trials

    Nov 1, 2016, 00:00

  • Characteristics and Quality of Life in Peripheral Arterial Disease(Pad) Patients In Korea- Results From Pad Outcomes Research

    Nov 1, 2016, 00:00

  • Exploring Bias in Meta-Analysis Due to Competing Risks and Different Data Types, with Application to Stroke Prevention in Atrial Fibrillation

    Nov 1, 2016, 00:00

  • Workload Analysis Of Parenteral Nutrition Services At Ministry Of Health Hospital In Saudi Arabia

    Nov 1, 2016, 00:00

  • Utility Values in Economic Models for Treatments of Schizophrenia

    Nov 1, 2016, 00:00

  • Budget Impact Analysis of Dasatinib in Imatinib-Resistant Or-Intolerant Patients with Chronic Phase Chronic Myeloid Leukemia (Cml-Cp) in the Chinese Setting

    Nov 1, 2016, 00:00

  • The Economic Burden of Pulmonary Embolism in Europe

    Nov 1, 2016, 00:00

  • Comparative Analysis of Indirect Costs Associated with Chronic Spontaneous/Idiopathic Urticaria-Results From The Assure-Csu Study In 7 Countries

    Nov 1, 2016, 00:00

  • Application Limitations of Cost Minimization Analysis in China

    Nov 1, 2016, 00:00

  • Description of the Impact of Hypertension on Hospitalisations for Cardiovascular Diseases in Japan Using a Japanese Claims Database

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Take Home-Naloxone for the Prevention Of Fatalities from Heroin Overdose in the UK

    Nov 1, 2016, 00:00

  • Continental Comparison of Innovative Drugs Prices, The Case of Oncology Used for Treatment of Solid Tumors in Germany and The United States

    Nov 1, 2016, 00:00

  • Performance of Search Filters to Identify Health State Utility Studies

    Nov 1, 2016, 00:00

  • A Comprehensive Economic Model for Dementia- Diagnosis, Disease Progression and Service Delivery

    Nov 1, 2016, 00:00

  • Reliability and Validity Study of the Finnish Adaptation of Scoliosis Research Society Questionnaire Version SRS-30

    Nov 1, 2016, 00:00

  • Trends In Utilization of Smoking Cessation Agents Before and After The Passage of Black Box Warning in The United States

    Nov 1, 2016, 00:00

  • Effectiveness of Photodynamic Therapy in Patients with Localized Esophageal Cancer

    Nov 1, 2016, 00:00

  • A Retrospective Study of Healthcare Costs in Patients with end Stage Lung Cancer During The Last Six Months of their Life

    Nov 1, 2016, 00:00

  • Cost of Outreach-Programme Toward Sex Workers in the NGO and Primary Health Center in Indonesia

    Nov 1, 2016, 00:00

  • The Safety And Effectiveness of Autologous Platelet Rich Plasma (Prp) Therapy For Lateral Epicondylitis- Systematic Reviews

    Nov 1, 2016, 00:00

  • Adjusted Comparison of Daratumumab Monotherapy Versus Real-World Historical Control Data From The Czech Republic in Heavily Pre-Treated and Highly Refractory Multiple Myeloma Patients

    Nov 1, 2016, 00:00

  • Recommendations In Clinical Guidelines, ‘No Benefit’ Ratings, And Opt-Out Decisions In Germany Since The Introduction Of The Amnog Law In 2011- How Do The Pieces Fit Together?

    Nov 1, 2016, 00:00

  • Quetiapine Off-Label Use

    Nov 1, 2016, 00:00

  • Efficacy, Costs And Quality Of Life In The Real World Setting For Patients With Multiple Sclerosis Treated With Fingolimod- Intermediate Results From The Virgile Study

    Nov 1, 2016, 00:00

  • Assessment Of Price Of Essential Medicines In India

    Nov 1, 2016, 00:00

  • Methods For The Design And Conduct Of Medical Record Reviews In Oncology

    Nov 1, 2016, 00:00

  • Literature Review On Morbidity and Mortality Endpoints in Melanoma Patients Under Treatment With GM-CSF or Dacarbazine

    Nov 1, 2016, 00:00

  • Towards more Transparent HTA Process in Poland – New Polish HTA Methodological Guidelines

    Nov 1, 2016, 00:00

  • prevalence of Anticholinergic Drug Use in Older Adults With Dementia

    Nov 1, 2016, 00:00

  • Real Time Patient Reported Outcomes Assessment in Routine Rheumatology Clinic - Feasibility Study of Myra Touch

    Nov 1, 2016, 00:00

  • Segmentation of Seven Asia-Pacific Health Technology Assessment (HTA) Agencies into Different Evolutionary HTA Archetypes

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Bisphosphonates for Primary and Secondary Prevention of Hip-Related Fracture with Glucocorticoid-Induced Osteoporosis in Malaysia

    Nov 1, 2016, 00:00

  • Predicting Response To Anti-Vascular Endothelial Growth Factor Treatment Using Electronic Medical Record Data In Eyes With Neovascular Age-Related Macular Degeneration

    Nov 1, 2016, 00:00

  • Comparative Analysis of Clinical Trial Attributes in Pivotal Studies for Orphan vs. Non-Orphan Oncology Products FDA-Approved between 2011 and 2015

    Nov 1, 2016, 00:00

  • Markov Model Projection Of Regional Physician Supply In Turkey Shows That Physician Density Will Not Change Substantially In The Next 15 Years

    Nov 1, 2016, 00:00

  • Utility Measures and Quality-Adjusted Life Years In Patients with Symptomatic Multivessel Coronary Artery Disease Assigned To Surgery, Angioplasty or Medical Treatment – Mass II Trial

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Ranibizumab Compared to Dexamethasone in Patients with Retinal Vein Occlusion (RVO) from A Portuguese Health Care Perspective

    Nov 1, 2016, 00:00

  • The Direct Cost-Components in Pulmonary Arterial Hypertension- An Expert Panel Approach for Estimation of Costs

    Nov 1, 2016, 00:00

  • Market Share of Addictology According To The System of Diagnosis Related Groups (DRGS) In Hungary

    Nov 1, 2016, 00:00

  • The Impact of External Price Referencing Within and Across a Country's Borders

    Nov 1, 2016, 00:00

  • Identification of Statin Intoleran Results From a Survey of Clinicians in Japan

    Nov 1, 2016, 00:00

  • Racial Differences in Cardiovascular Disease in The United States- Healthcare Resource Utilization and Costs

    Nov 1, 2016, 00:00

  • Effectiveness and Safety of Thrombolytic Agents Streptokinase, Alteplase and Tenecteplase in the Treatment of Acute Myocardial Infarction

    Nov 1, 2016, 00:00

  • Health-Related Quality of Life of Patients in Primary Care and Multimorbity

    Nov 1, 2016, 00:00

  • Development of a Global Model for the Economic Evaluation of Pharmacogenomics Tests for Early-Stage Breast Cancer Treatment

    Nov 1, 2016, 00:00

  • Discordance Between Knowledge of Cardiovascular Risk Factors and Ideal Cardiovascular Health in Hong Kong Adults

    Nov 1, 2016, 00:00

  • Mapping of Existing Data Sources for the Conduct of Real-World Studies in Progressive Supranulcear Palsy (PSP) in North America, Europe and Japan

    Nov 1, 2016, 00:00

  • Comparison of Orphan Drug Market Access in A Sample of EU Countries, Ausralia, Canada and US

    Nov 1, 2016, 00:00

  • A Dynamic Simulation to Investigate Health Economic Impact of a Pulmonary Artery Pressure Sensor for Heart Failure Telemonitoring

    Nov 1, 2016, 00:00

  • Assessment of Utility for Heart Failure using Visual Analogue Scale(VAS), Time-Trade off(TTO) and Euroqol-5 Dimension(EQ-5D) in the Korean General Population

    Nov 1, 2016, 00:00

  • Non-Valvular Atrial Fibrillation- Can We Improve Health Outcomes?

    Nov 1, 2016, 00:00

  • Economic Burden of Myelodysplastic Syndromes In Croatia

    Nov 1, 2016, 00:00

  • The Behaviour Of Pharmacists In Public Pharmacies In Relation To The Cold Regime Drugs

    Nov 1, 2016, 00:00

  • Evaliation of Utility Index of Quality of Life In Hepatitis Patients in Japan

    Nov 1, 2016, 00:00

  • Evaluation of Breast Cancer HER2 Status Accuracy Using A Predictive Model Based on Her-France Real World National Database

    Nov 1, 2016, 00:00

  • Using Analytic Hierarchy Process to Weight Patient-Relevant Outcomes in the Treatment of Psoriasis for Calculating the Patient Benefit Index

    Nov 1, 2016, 00:00

  • Economic Evaluation of Cancer Medicines Usage at Uganda Cancer Institute

    Nov 1, 2016, 00:00

  • Lost in Translation- Randomised Controlled Trial and Systematic Review Evidence of Intracoronary Versus Intravenous Abciximab in St-Elevation Myocardial Infarction

    Nov 1, 2016, 00:00

  • Economic Evaluation Of Yellow Fever Routine Vaccination In Colombia

    Nov 1, 2016, 00:00

  • Epidemiology, Treatment Pathways and Costs of Cancers Potentially Related to HPV Infection in France

    Nov 1, 2016, 00:00

  • Health Related Quality of Life for Disease Population in China- A Systematic Review

    Nov 1, 2016, 00:00

  • Quality of Life Measured with Eq-5d in Patients with Major Depressive Disorder in Japan

    Nov 1, 2016, 00:00

  • Reliability and Validity of the Short-Form 36 (SF-36) Health Survey in Patients with Spondyloarthritis

    Nov 1, 2016, 00:00

  • A Study Comparing the Evolution of Different Proceeses for Patient Input in Different European HTA Systems Since 2011

    Nov 1, 2016, 00:00

  • The Impact Of Regional Legislative Measures On The Prescription Of Off-Patent Medicines

    Nov 1, 2016, 00:00

  • Factors Associated with The Mental and Physical Health-Related Quality of Life (HRQOL) of Asthma Patients- A Cross-Sectional Analysis Based On 673 Patients

    Nov 1, 2016, 00:00

  • Comparative Effectiveness of Carbapenems Versus Alternative Antibiotics for the Treatment of Bacteraemia Due to Enterobacteriaceae Producing Extended-Spectrum β-Lactamase in Empirical Therapy- Multicenter Cohort Study

    Nov 1, 2016, 00:00

  • Nintedanib Cost-Effectiveness In Idiopathic Pulmonary Fibrosis In The UK

    Nov 1, 2016, 00:00

  • Estimating the Impact of Direct-to-Consumer Advertising of Pharmacy Only Medicine Using Discrete Choice Experiments

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Exenatide Once Weekly Versus Insulin Glargine and Liraglutide for the Treatment of Type 2 Diabetes in Greece

    Nov 1, 2016, 00:00

  • Provisions and Special Considerations for Rare Diseases / Orphan Drugs by Health Technology Assessment (HTA) Bodies- Systematic Evaluation in 25 Countries

    Nov 1, 2016, 00:00

  • The Effectiveness of Lean Body Mass Analysis Using Dual Energy X-Ray Absorptiometry (DEXA) for Diagnosis of Sarcopenia

    Nov 1, 2016, 00:00

  • Length of Stay, Costs and Mortality Attributable to Clostridium Difficile Infections in 13 Belgian Hospitals

    Nov 1, 2016, 00:00

  • Personalized Adaptive Rewards Versus Incentives to Motivate Sustainable Healthy Behavioral Change- A Neo-Maslowian Conceptual Model

    Nov 1, 2016, 00:00

  • Cost and Burden of Female Breast Cancer in Portugal

    Nov 1, 2016, 00:00

  • Analysis Of Influenza Vaccination Effectiveness In General Practitioner

    Nov 1, 2016, 00:00

  • Role of Tiered Pricing Policy in Improving Access to Medicines in India

    Nov 1, 2016, 00:00

  • Economic Burden of Hospitalization for Hepatic Encephalopathy in Fran An Analysis of Cost Discriminating Factors By Patient Profile

    Nov 1, 2016, 00:00

  • Amnog Early Benefit Assessment (EBA) in Germany - A Specific Challenge for Antidiabetics

    Nov 1, 2016, 00:00

  • Medication Errors Avoided by Medication Reconciliation Process at Female Surgery Ward in Ramathibodi Hospital, Thailand

    Nov 1, 2016, 00:00

  • Free Essential Medicines Through Public Health Facilities in Nepal- A Qualitative Study

    Nov 1, 2016, 00:00

  • The Epidemiology and Cardiovascular Disease Risk Assessment of Patients Currently on Lipid Lowering Treatment with Statin- Nationwide Cross-Sectional Study in Korea

    Nov 1, 2016, 00:00

  • Impacts of Adverse Events on Health-Related Quality of Life in Patients Receiving First-Line Chemotherapy for Metastatic Breast Cancer- Results From Randomized Phase III Select BC Study

    Nov 1, 2016, 00:00

  • Impact of Etanercept Biosimilar Launches on Healthcare Spending- A UK Budget Impact Model For The Treatment of Rheumatoid Arthritis And Chronic Plaque Psoriasis

    Nov 1, 2016, 00:00

  • Assessing Patient Preference for Insulin Intensification in France

    Nov 1, 2016, 00:00

  • Pharmacoeconomics Analysis of ACEI and ARB Against Essential Hypertension- A Case Study of Shanghai

    Nov 1, 2016, 00:00

  • Impact of a Community Pharmacy-Based Information Program on Type 2 Diabetic Patients’ Adherence to Their Oral Treatment- Iphodia, A Cluster Randomized Study Vs Usual Practice

    Nov 1, 2016, 00:00

  • What is Real-World Data?- A Review of Definitions Based on Literature Stakeholder Interviews

    Nov 1, 2016, 00:00

  • Feasibility, Reliability and Validity of The Decision Tool Unipolar Depression (DTUD) In Identifying Patients with Major Depressive Disorder in Need of Highly Specialized Care

    Nov 1, 2016, 00:00

  • Does Real World Evidence Support Conclusions From Experimental Evidence In Decision-Making Processes In Poland?

    Nov 1, 2016, 00:00

  • Economic Resources Optimisation In The Hcv Setting- The Role Of The Daas

    Nov 1, 2016, 00:00

  • Cost-Utility Analysis Evaluating Vortioxetine Versus Venlafaxine XR and Agomelatine in the Treatment of Major Depressive Disorder in Taiwan

    Nov 1, 2016, 00:00

  • Review Of National Policies For Rare Diseases Across Eu Countries

    Nov 1, 2016, 00:00

  • Economic Impact of Olaparib in Patients with Platinum Sensitive Relapsed Brca Mutated Epithelial Ovarian Cancer in Spain

    Nov 1, 2016, 00:00

  • Complete Remission and Survival Ratio Comparison Between Transplant and Non-Transplant AML Patients Receiving Standard Regimen in a Malaysian Hospital

    Nov 1, 2016, 00:00

  • Current Perioperative Use of Orodental Antiseptics In Implant Surgery In Bulgaria

    Nov 1, 2016, 00:00

  • A Review of Pharmeceutical Policies in Response to Economic Crisis and Sanctions

    Nov 1, 2016, 00:00

  • Costs And Outcomes Of Hospital Infections In Italy

    Nov 1, 2016, 00:00

  • Strategic Considerations to Engage in Early Advice with European Health Technology Assessment Bodies

    Nov 1, 2016, 00:00

  • Burden of Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome (ACOS)

    Nov 1, 2016, 00:00

  • A Retrospective, Cross Sectional Study on The Prevalence of Hyperuricemia Using A Healthcare Database In Japan

    Nov 1, 2016, 00:00

  • Acute Respiratory Distress Syndrome Profile at a Tertiary Care Teaching Hospital in South India

    Nov 1, 2016, 00:00

  • Japan Health Care Act Reform- Toward Decentralization And Integrated Health Care System

    Nov 1, 2016, 00:00

  • Effectiveness of Photodynamic Therapy in Patients with Non-Small Cell Lung Cancer- A Population Based Study

    Nov 1, 2016, 00:00

  • Impact of Community Care Subsidies on Care Use Of Elderly People

    Nov 1, 2016, 00:00

  • Metastatic Colorectal Cancer- The Burden of Illness in The Uk and Ireland

    Nov 1, 2016, 00:00

  • Medical Costs Attributable To Obesity In Working Osteo-Arthritis Patients In The US

    Nov 1, 2016, 00:00

  • Antimicrobial Susceptibility Pattern in Chronic Suppurative Otitis Media Patient in a Tertiary Care Hospital

    Nov 1, 2016, 00:00

  • The Economic Impact of Schizophrenia from an English NHS Perspective Based on Estimates from Electronic and Self-Reported Methods of Data Collection

    Nov 1, 2016, 00:00

  • Prescription Patterns and Drugs Costs in Patients with Dementia - A Retrsopective Database Analysis

    Nov 1, 2016, 00:00

  • Study of Contrast Induced Nephropathy in Patients Undergoing Cardiac Catheterization- Upper Egypt Experience

    Nov 1, 2016, 00:00

  • Rationing Resources in Health By Involving the Public in Priority Setting

    Nov 1, 2016, 00:00

  • Effects of The Mental Health Parity and Addictions Equality Act on Depression Treatment Choice in Primary Care Facilities in The United States

    Nov 1, 2016, 00:00

  • Physical Activity and Health-Related Quality of Life Among Adults with Type 2 Diabetes- Results from Wearable Fitness Trackers

    Nov 1, 2016, 00:00

  • Long-Term Healthcare Costs of Patients with Symptomatic Peripheral Artery Disease with and without a History of Atherosclerotic Disease- Results from a Swedish Nationwide Study

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis for Apixaban in The Acute Treatment and Prevention of Venous Thromboembolism in The Netherlands

    Nov 1, 2016, 00:00

  • Patient Preferences Versus Physician Perceptions Of Treatment Decisions In Advance Stage Prostate Cancer

    Nov 1, 2016, 00:00

  • Real-World Outcomes of Novel Treatments in Patients with Advanced Melanoma in The Netherlands

    Nov 1, 2016, 00:00

  • Adoption of Oncology Biosimilars in Europe

    Nov 1, 2016, 00:00

  • Estimation Of Value Of Life With A Model Approach Depending On Net Present Value For Austria, Canada, Japan And Usa

    Nov 1, 2016, 00:00

  • Cost-Utility Analysis of Sacubitril/Valsartan for The Treatment of Chronic Heart Failure in Greece

    Nov 1, 2016, 00:00

  • Cost-Utility Analysis of Atazanavir/Ritonavir 200/100 Mg Versus Atazanavir/Ritonavir 300/100 Mg in Thai Adults with Virologic Suppression

    Nov 1, 2016, 00:00

  • Receipt and Delivery of Medication Risk and Safety Information- Perceptions of Consumers and Healthcare Professionals (HCPS) in the US

    Nov 1, 2016, 00:00

  • Economic Evaluation of Pertuzumab Neoadjuvant Treatment for Patients with Locally Advanced, Inflammatory, or Early Stage HER2-Positive Breast Cancer in Greece

    Nov 1, 2016, 00:00

  • The 21-Gene Assay In The Decision Impact Assessment of ER+, HER2- Breast Cancer- A French Real Life Prospective Study

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Evaluation of Vortioxetine in Major Depressive Episode in the UK Setting

    Nov 1, 2016, 00:00

  • Adherence To Gold Criteria Strategy In Treatment of Chronic Obstructive Pulmonary Disease (COPD) Patients- Cost Implications In Turkey

    Nov 1, 2016, 00:00

  • Identification of Statin Intoleran Results From A Survey of South Korean Clinicians

    Nov 1, 2016, 00:00

  • Use of the Pert and Uniform Distributions with the Central Limit Theorem (CLT) to Decrease Variance in Complication Cost Estimation in Probabilistic Models

    Nov 1, 2016, 00:00

  • Quality of Life in Patients with Diabetes Mellitus II in Czech Republic

    Nov 1, 2016, 00:00

  • Early HTA in Pharmacogenomics- A Case Example in Cardiovascular Drugs

    Nov 1, 2016, 00:00

  • Effectiveness of Pharmacists-Led Provider-Focused Interventions to Improve Hpv Vaccination Rates in Adults in Malaysia

    Nov 1, 2016, 00:00

  • An Analysis of the Efficacy and Safety of Edoxaban in Comparison with Rivaroxaban in the Treatment of Deep Vein Thrombosis and Pulmonary Embolism

    Nov 1, 2016, 00:00

  • Development of Reimbursement of New Examination and Treatment Methods (NUB) in the German DRG-System – Analysis of NUB Applications and NUB Status Since Implementation

    Nov 1, 2016, 00:00

  • Economic Burden of Medical Transports In France over The Year 2014

    Nov 1, 2016, 00:00

  • Micro-Costing Analysis of Procedures on Varicose Veins Performed in Outpatient Setting

    Nov 1, 2016, 00:00

  • Real-World Treatment Patterns and Costs of Care Among Brentuximab Vendotin-Treated Patients with Hodgkin Lymphoma in The United States

    Nov 1, 2016, 00:00

  • Cost Analysis of the Molecular Screening and Genetic Diagnosis of Lynch Syndrome in Catalonia (Spain)

    Nov 1, 2016, 00:00

  • Types of Risk-Sharing Schemes Proposed in Reimbursement Application Received by Aotmit in 2015

    Nov 1, 2016, 00:00

  • Monitoring Evidence-Based Technology Incorporation- The Case of Biological Rheumatoid Arthritis Drugs In Brazil From 2010 to 2014

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Of Levofloxacin Inhalation Solution Vs. Aztreonam Inhalation Solution In Cystic Fibrosis Patients In Belgium

    Nov 1, 2016, 00:00

  • Relationship Between Orphan Disease Prevalence, Differential Hta Value Assessment, And Orphan Drug Pricing In Seven European Countries

    Nov 1, 2016, 00:00

  • Real-World Outcomes of Ipilimumab in Patients with Advanced Melanoma in The Netherlands

    Nov 1, 2016, 00:00

  • A Cost-Minimization Analysis of Dermatophyte Test Kit with Onychomycosis Under Health Care System in Japan

    Nov 1, 2016, 00:00

  • The Public Health Perspective Of An Investigational Herpes Zoster Vaccine In The United Kingdom (Uk)

    Nov 1, 2016, 00:00

  • On a Design Issue of EQ-5D-3l Valuation Studies- Should Likelihood of the Health States Be Considered?

    Nov 1, 2016, 00:00

  • Costs and Clinical Outcomes in The Management of Metastatic Castration-Resistant Prostate Cancer in Greece

    Nov 1, 2016, 00:00

  • Tamoxifen for the Primary Prevention of Breast Cancer- New Life for an Old Drug

    Nov 1, 2016, 00:00

  • Comparison of Methods for Indirect Treatment Comparison Combining Individual and Aggregate Patient Data- A Simulation

    Nov 1, 2016, 00:00

  • The Economic Cost Of Blindness in Europe

    Nov 1, 2016, 00:00

  • Health Related Quality of Life Among Patients with Heart Failure in South Korea

    Nov 1, 2016, 00:00

  • The Evaluation of Innovative Drugs Applying Business Valuation Concepts

    Nov 1, 2016, 00:00

  • Assessment Of Clinical And Economic Outcomes Of Pharmacist Intervention In Total Parenteral Nutrition Program In Saudi Arabia

    Nov 1, 2016, 00:00

  • CT And MRI Units In Cyprus- A Market Analysis

    Nov 1, 2016, 00:00

  • Patient Preferences In The Treatment of Neovascular Age-Related Macular Degeneration- A Discrete Choice Experiment

    Nov 1, 2016, 00:00

  • Analysis of the Indicator "Threshold Willingness To Pay" in Leukemia Patients by Gender According to the Survey in Ukraine

    Nov 1, 2016, 00:00

  • Albuminuria and Serum Creatinine in Predicting Renal Function Decline in Patients with Diabetic Nephropathy- A Systematic Literature Review

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Secukinumab Compared with Ustekinumab And Etanercept for the Treatment Of Moderate-to-Severe Plaque Psoriasis in Greece

    Nov 1, 2016, 00:00

  • A Cost of Illness Analysis of Pulmonary Arterial Hypertension in Greece

    Nov 1, 2016, 00:00

  • Prevalence and Environmental Risk Factors of Self-Reported Acne in Mexico

    Nov 1, 2016, 00:00

  • Epidemiology of Chronic Kidney Disease and Predictors of Hyperkalemia- Analysis of Nhanes 2007–2014

    Nov 1, 2016, 00:00

  • Treatment Gap of Ulcerative Colitis In Children And Adolescents In Poland - Cost-Utility Analysis of Biosimilar Infliximab

    Nov 1, 2016, 00:00

  • Cost-Utility Analysis of Lorcaserin In The Treatment of Obesity

    Nov 1, 2016, 00:00

  • Metformin Treatment and Homocysteine- A Systematic Review and Meta-Analysis of Randomized Controlled Trials

    Nov 1, 2016, 00:00

  • A Methodological Issue in Effectiveness Studies of Malaria Vaccines and Chemoprevention

    Nov 1, 2016, 00:00

  • A Cost-Effectiveness Analysis of Biosimilar Infliximab (Inflectra®) For The Treatment of Psoriatic Arthritis In Nine European Countries

    Nov 1, 2016, 00:00

  • The Impact on Long-Term Targeted Therapy with Omalizumab on The Quality of Life According To Registry of Children with Uncontrolled Severe Persistent Asthma (Russian Experience)

    Nov 1, 2016, 00:00

  • Cost Effectiveness of Contrast-Enhanced Liver MRI in the Characterisation of Suspected Liver Lesions in Patients with Colorectal Cancer

    Nov 1, 2016, 00:00

  • Use of Clinical Intelligence in Monitoring Rational Drug Use Indicators in Thailand

    Nov 1, 2016, 00:00

  • Comparison Study Based on Simulation of Patient Pathways Using Multi-State Models in Oncology

    Nov 1, 2016, 00:00

  • The Cost of Remaining NTM Positive- Health Care Utilization and Costs In A Sample of Patients with Refractory Pulmonary Disease Due To Mycobacterium Avium Complex In Canada, Germany, United Kingdom And France

    Nov 1, 2016, 00:00

  • The Public Health Impact Of A New Herpes Zoster Vaccine To The German Population

    Nov 1, 2016, 00:00

  • Assessing The Outcomes of Prosthetic Treatment in Lower Overdenture Wearers

    Nov 1, 2016, 00:00

  • Current Practice of Drug Treatment In Children with ILD- First Insights From The Child-Eu Registry

    Nov 1, 2016, 00:00

  • A Comparative Analysis on Health Security System Between China and Developed Countries

    Nov 1, 2016, 00:00

  • The Costs of Rheumatoid Arthritis In Finland

    Nov 1, 2016, 00:00

  • Health-Related Quality of Life for People Suffering from Severe Chronic Low Back Pain with a Neuropathic Component- Results from a Post-Hoc Analysis of Randomly Selected Routine Data, Evaluated By Response to Treatment

    Nov 1, 2016, 00:00

  • Accuracy Of Natural Language Processing-Based Classifiers For Automated Identification Of Abstracts Of Studies On Humanistic And Economic Burden Of Disease

    Nov 1, 2016, 00:00

  • Economic Evaluation of ASA 100mg, Simvastatin 40mg and Ramipril 5-10mg (POLYPILL) for Secondary Prevention of Cardiovascular Events in Mexico

    Nov 1, 2016, 00:00

  • A Time and Motion Cost Analysis of Oral Vinorelbine Versus Iv Chemotherapies For Patients with Advanced Non-Small Cell Lung Cancer (Nsclc) and Metastatic Breast Cancer (Mbc)From Chinese Societal Perspective

    Nov 1, 2016, 00:00

  • A Retrospective Study on The Management of Primary Immune Thrombocytopenia In Adult Patient In Hong Kong

    Nov 1, 2016, 00:00

  • Understanding Racial And Ethnic Differences In End of Life Care For Hospitalized Patients

    Nov 1, 2016, 00:00

  • The Effect of Diabetes on the Quality-of-Life in Community-Dwelling Elderly in The Netherlands

    Nov 1, 2016, 00:00

  • Modeling The Impact Of Reform To The Cancer Drugs Fund

    Nov 1, 2016, 00:00

  • Health Care Resource Utilization and Costs Associated with the Management of Non-Infectious Intermediate, Posterior and Panuveitis in Canada

    Nov 1, 2016, 00:00

  • Risk of Cardiovascuar Disease in Type 2 Diabetic Women on Sulfonylureas-A Retrospective Case-Control Study

    Nov 1, 2016, 00:00

  • The Burden of Inflammatory Bowel Disease(IBD) in Japan

    Nov 1, 2016, 00:00

  • Reducing disparities in u.s. Vaccination through senior centers- A Comparison of three Educational Models for Older African Americans

    Nov 1, 2016, 00:00

  • Assessment of the Costs of Overall Children Vaccination with Antirotavirus Vaccine in Ukraine

    Nov 1, 2016, 00:00

  • Assesing The Average Price Level Of Generics In Greece And Other Comparable European Countries Relative To Their Volume Market Share

    Nov 1, 2016, 00:00

  • Predicting Patient-Reported Outcomes from Disease-Specific Questionnaires- A Comparison of Seven Methodologies

    Nov 1, 2016, 00:00

  • Two Models of Public Educations, Storytelling Animated Movies- Cons And Pros

    Nov 1, 2016, 00:00

  • Adoption of Endoscopic Lung Volume Reduction for Emphysema in Germany- Utilization Patterns and Case Volumes in the Period 2010-2014

    Nov 1, 2016, 00:00

  • Orphan Drug Shortage in The United States- A Long Lasting Public Health Issue Calling for Effective Policies

    Nov 1, 2016, 00:00

  • Italian Timings In New Drugs Approval- An Up-To-Date Analysis

    Nov 1, 2016, 00:00

  • Healthcre Reform Plan and Price Elasticity in Vaginal Delivery- A Case Study in Iran

    Nov 1, 2016, 00:00

  • Estimating an Icer with NOAC Versus Warfarin in Atrial Fibrillation

    Nov 1, 2016, 00:00

  • Inpatient Costs of Agitation and Containment in an Urban Area

    Nov 1, 2016, 00:00

  • The Benefits of A Holistic View- Considering Multiple Health Outcomes for Hiv and Sti Testing

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Evaluation Of Phid-Cv Versus Pcv-13 In Poland

    Nov 1, 2016, 00:00

  • Treatment Efficacy in Sequence Modelling – A Review of Published Approaches

    Nov 1, 2016, 00:00

  • Effect of Drug Cost-Sharing Change on Non-Adherence to Essential Medications for Acute Coronary Syndrome- A Population Based Natural Experiment

    Nov 1, 2016, 00:00

  • Economic Evaluation Guideline for Pharmaceuticals and Medical Devices in Japan

    Nov 1, 2016, 00:00

  • Economic Assessment of Routine Oncotype DX Testing of Estrogen Receptor Positive (ER+) Early Breast Cancer (EBC) Patients with Grade 2 Tumours in Czech Republic

    Nov 1, 2016, 00:00

  • Evaluation of Antimicrobial Stewardship Programs in Hainan, China

    Nov 1, 2016, 00:00

  • German Travelers’ Preferencences For Vaccines Against Travel-Related Illnesses

    Nov 1, 2016, 00:00

  • Long-Term Improvements in Workplace and Household Productivity and Social Participation Over 4 Years of Certolizumab Pegol Treatment in Patients with Psoriatic Arthritis, with and without Prior Anti-Tnf Exposure

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Using Factor VII + Von Willebrand Factor In Treatment of Patients with Von Willebrand Disease

    Nov 1, 2016, 00:00

  • Study of Prescribing Pattern of Anti-Diabetic Drugs in Newly Diagnosed Type 2 Diabetes Mellitus

    Nov 1, 2016, 00:00

  • Effect Of A Pay-For-Performance Program For Diabetes On Health Status (Eq-5d) In Taiwan

    Nov 1, 2016, 00:00

  • Dose Escalation of Biologics in Crohn’s Disease- Summary of Observational Studies in the UK

    Nov 1, 2016, 00:00

  • Analysis of Rational Medication for Cardiovascular Diseases in Fujian, China

    Nov 1, 2016, 00:00

  • Advanced Therapy Medicinal Products for Alzheimer's Disease Will Shrink the National Health Service Budget

    Nov 1, 2016, 00:00

  • Prompt Value Assessment Of Breakthrough Interventions With Limited Outcome Data

    Nov 1, 2016, 00:00

  • Type 2 Diabetes- How Much Does it Cost During the First 8 Years after the First Antidiabetic Treatment? A Dynamic Approach from the French National Health Insurance

    Nov 1, 2016, 00:00

  • Cross-Cultural Adaptation of the Zarit Caregiver Interview for Alzheimer's Disease (ZCI-AD) and the Caregiver Global Impression Scales in 13 Languages

    Nov 1, 2016, 00:00

  • Persistence with Biologic Agents for the Treatment of Rheumatoid Arthritis in Japan

    Nov 1, 2016, 00:00

  • Towards Better Coordination and More Efficient Patient Pathways in Copd

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Diagnostic Tests for People At Risk of Non-Alcoholic Fatty Liver Disease (NAFLD) in The UK

    Nov 1, 2016, 00:00

  • Examining The Association Between Corticosteroid Exposure and New Onset Type 2 Diabetes Among Commercially Insured Copd Patients In The US

    Nov 1, 2016, 00:00

  • A Systematic Review and Meta-Analysis of the Prevalence and Complications of Paraphenylene Diamine (PPD) Containing Hair Dye Poisoning in Developing Countries

    Nov 1, 2016, 00:00

  • Retrospecive Patient Chart Study to Evaluate Real Life Treatment and Event Rate of Patients Surviving Their Myocardial Infarction for at Least 12 Months

    Nov 1, 2016, 00:00

  • Upcoming Regulations on Insurance Reimbursement Standard in China- Chanllanges and Opportunites for Mncs

    Nov 1, 2016, 00:00

  • Economic Burden of Heart Failure in Chinese Population

    Nov 1, 2016, 00:00

  • Patients' Preferences For Characteristics Of Periodontal Disease And Its' Treatment- A Discrete Choice Experiment

    Nov 1, 2016, 00:00

  • ASSESSMENT OF PET/CT USE IN RADIOTHERAPY PLANNING VERSUS CT SCANS USE ONLY

    Nov 1, 2016, 00:00

  • The Economic Burden of Four Heart Conditions in Latin America

    Nov 1, 2016, 00:00

  • “Causal Cascade” Among Outcomes in Non-Small Cell Lung Cancer- Assessing The Direct and Indirect Effects of Symptoms on Health-Related Quality of Life (HRQL) Outcomes

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Comprehensive Medication Review (CMR) for Patients Acutely Admitted to Hospital

    Nov 1, 2016, 00:00

  • Comparing Eq-5d-3l And Eq-5d-5l In A General Population

    Nov 1, 2016, 00:00

  • What Drives ASMR of Orphan Drugs?

    Nov 1, 2016, 00:00

  • Understanding Health Technology Assessment (HTA) Bodies in Major European Markets- Systematic Evaluation in 10 EU Countries

    Nov 1, 2016, 00:00

  • The Impact of Dynamic Transmission Modelling on the Estimated Cost-Effectiveness of Treatment for Chronic Hepatitis C in The United Kingdom

    Nov 1, 2016, 00:00

  • Quinolones Utilization In Two Tertiary Hospitals In Nigeria; Exploring Drug Use Towards Improved Treatment Outcomes

    Nov 1, 2016, 00:00

  • Level of Informedness about Colorectal Cancer Screening Among Lay Persons

    Nov 1, 2016, 00:00

  • The Therapeutic Indication of Injectable Bevacizumab to The Treatment of Age-Related Muscular Degeneration

    Nov 1, 2016, 00:00

  • Epidemiology of Insulin-Treated Diabetic Patients in French Regions- A Retrospective Cross-Sectional Analysis of National Health Insurance Claims Databases

    Nov 1, 2016, 00:00

  • Pharmaceutical Tracking System- An Improvement in Data Accuracy and Uses

    Nov 1, 2016, 00:00

  • Developing A Classification System of Patients Based on Risk Related to Epidemiological and Demographic Variables

    Nov 1, 2016, 00:00

  • Hospitalization Costs Associated with Crohn's Disease and Ulcerative Colitis in Belgium

    Nov 1, 2016, 00:00

  • Modelling the Cost-Effectiveness of Treatment Strategies in Chronic Lymphocytic Leukaemia, Follicular Lymphoma and Multiple Myeloma- A Review and Critical Appraisal of the Published Literature

    Nov 1, 2016, 00:00

  • Investigation Of The Work Ability Of Nurses And Its Influencing Factors

    Nov 1, 2016, 00:00

  • Effectiveness of Trigger Tools to Detect Adverse Drug Events from Discharge Summaries- A Retrospective Study

    Nov 1, 2016, 00:00

  • Breast Cancer In Japan- Room For Improved Screening

    Nov 1, 2016, 00:00

  • Long-Term Health-Related Economic Burden of Adult Congenital Heart Diseases in Hong Kong

    Nov 1, 2016, 00:00

  • Comparing Costs from a Pragmatic Randomised Trial to Published Modelling-Based Estimates- An Example from Prostate-Cancer Screening

    Nov 1, 2016, 00:00

  • Retrospective Database Analysis on Anaphylaxis And Patient Concordance In The United States

    Nov 1, 2016, 00:00

  • Is There an Association Between Diabetic Microvascular Complications and Serum Cholesterol? a Retrospective Analysis among Malaysian Patients with T2DM

    Nov 1, 2016, 00:00

  • Words (Excluding Tãtle and Authors- 300) Title- Cost-Effectiveness Analysis of Nivolumab for the Treatment of Second-Line Advanced Squamous Non-Small Cell Lung Cancer (Nsclc) in Spain

    Nov 1, 2016, 00:00

  • The Association Between Disability And Early Exit From Work In Osteoarthritis

    Nov 1, 2016, 00:00

  • Health Technology Assessment Supports Evidence-Based Decision-Making in The Changi General Hospital Marketplace Exercise

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Nivolumab + Ipilimumab in First-Line Treatment of Advanced Melanoma

    Nov 1, 2016, 00:00

  • Clinical And Economic Impact Of Pharmacist Intervention At Critical Care Of Private Hospital In Riydah, Saudi Arabia

    Nov 1, 2016, 00:00

  • Bayesian Network of Disease History

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Sacubitril/Valsartan in Heart Failure with Reduced Ejection Fraction in Sweden

    Nov 1, 2016, 00:00

  • A Comparison of EQ-5D-3L Index Scores Using Foreign Value Sets for Indonesian Sample with Cervical Cancer

    Nov 1, 2016, 00:00

  • Do More Men or Women with T2DM Achieve their Glycaemic Targets? An Exploratory Malaysian Study

    Nov 1, 2016, 00:00

  • Implications of Introducing Patient Heterogeneity in Cost Effectiveness Modeling

    Nov 1, 2016, 00:00

  • The Value of Mcda in Health Technology Assessment- A Explorative Study in the Dutch Context

    Nov 1, 2016, 00:00

  • Epidemiological Estimation and Flow of Patients with Advanced Renal Cell Carcinoma Who Have Received Prior Anti-Angiogenic Therapy in Spain

    Nov 1, 2016, 00:00

  • Attitude And Willingness To Participate on Screening of First-Degree Relatives of Colorectal Cancer Patients

    Nov 1, 2016, 00:00

  • Situation and Impact of Insulin Pen Needle Reuse for Patients with Diabetes in China

    Nov 1, 2016, 00:00

  • Cost Analysis of Therapy with Idursulfase For Hunter Syndrome In Bulgaria

    Nov 1, 2016, 00:00

  • Balancing Commercial Confidentiality with Accountability- A Proposal for Enhanced Disclosure of Cost-Effectiveness Decisions

    Nov 1, 2016, 00:00

  • Epidemiology and Survival in Prostate Cancer; A Population Based Study Analysing The Hungarian National Health Insurance Found Database

    Nov 1, 2016, 00:00

  • An Exploration of Techniques for Addressing Uncertainty in Survival Estimates used Within Partitioned-Survival Models

    Nov 1, 2016, 00:00

  • Utilization of Topical Tacrolimus and Topical Pimecrolimus in Europe- Results From The Joint European Longitudinal Lymphoma and Skin Cancer Evaluation (Joelle) Study

    Nov 1, 2016, 00:00

  • Boosting a Modeller's Armoury- Pursuing Realistic and Efficient Competing Risk Health Economic Models (HEMS)

    Nov 1, 2016, 00:00

  • Cost-minimization Analysis of Pegaspargase And Native E. Coli Asparaginase To Treat Children And Adults with Acute Lymphoblastic Leukemia In Belgium

    Nov 1, 2016, 00:00

  • Universal Health Coverage in Countries Across East and Southeast Asia – Associations Between Health Expenditure and Service Provision

    Nov 1, 2016, 00:00

  • Overall Survival Versus Progression-Free Survival in Oncology Clinical Trials

    Nov 1, 2016, 00:00

  • Incremental Direct And Indirect Costs Associated With Migraine In The Us

    Nov 1, 2016, 00:00

  • Budget Impact Analysis of First-Line Treatment with Branded Pemetrexed (ALIMTA) for Advanced Non-Squamous Non-Small Cell Lung Cancer in China

    Nov 1, 2016, 00:00

  • Clinical And Economic Analysis Of Two Surfactants For The Prevention And Treatment Of Respiratory Distress Syndrome

    Nov 1, 2016, 00:00

  • Evaluation of Glycemic Control with the Combination of Biphasic Insulin and Metformin Therapy in Type 2 Diabetes Mellitus Patients

    Nov 1, 2016, 00:00

  • Prevalence, Perception And Reasons For Self Medication

    Nov 1, 2016, 00:00

  • Impact of Patient Race and Geography on Access and use of Adjuvant Endocrine Therapy in Medicare Breast Cancer Survivors

    Nov 1, 2016, 00:00

  • A CPRD-HES Database Study of Back Pain In The UK- Incidence And Prevalence

    Nov 1, 2016, 00:00

  • Cost-Utility Analysis of Herpes Zoster Vaccine in Thailand

    Nov 1, 2016, 00:00

  • Are We Indeed Fast Adopters As We Claim To Be? An Analysis Of The Time Interval From Regulatory Approval To Coverage And Reimbursement In The National List Of Health Services In Israel

    Nov 1, 2016, 00:00

  • Evaluating The Economic Burden and Health Care Utilization of Lung Cancer in The Us Medicare Population

    Nov 1, 2016, 00:00

  • Preliminary Evaluation Of “Introducing Immigrants To The Healthcare System In Chile” Pilot Programme

    Nov 1, 2016, 00:00

  • HTA Agencies Perspective on Progression-Free-Survival (PFS)

    Nov 1, 2016, 00:00

  • Utilisation and Expenditure Beyond HTA- A Case Study of Lidocaine 5% Medicated Plaster

    Nov 1, 2016, 00:00

  • Social and Economic Burden of Skin Disease in Europe. A Narrative review of the Literature

    Nov 1, 2016, 00:00

  • Impact of Dosing Schedule on the Success of A Vaccination Programme in an Elderly Population

    Nov 1, 2016, 00:00

  • Monitoring Treatment Response in Metastasic Colorectal Cancer- Economic Evaluation Of CTC-Test Versus CT Scan

    Nov 1, 2016, 00:00

  • Scientific Epidemiology and Health Economics- A Retrospective Analysis on Pesticide Consumption and Survivors in Telangana State-India

    Nov 1, 2016, 00:00

  • The Role of Pharmacy Information Systems, Formulary Arrangmnet,Supplay Chain And Distrbution System To Improve Patients' Access To Prescription Drug In Saudi Hospitals- A Cross-Sectional Descriptive Study

    Nov 1, 2016, 00:00

  • Direct Medical Costs of Hcv Patients Using National Health Insurance Claims Data in South Korea

    Nov 1, 2016, 00:00

  • Analysis of Affordability and Consumption of Antihypertensive Fixed Combinations of Drugs in Ukraine

    Nov 1, 2016, 00:00

  • Short And Long Term Costs Associated With Different Cardiovascular Events In Belgium

    Nov 1, 2016, 00:00
  • «
  • 81
  • 82
  • 83 (current)
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • »